The Antimicrobial Potential of the Neem Tree Azadirachta indica
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Azadirachta indica(A. Juss), also known as the neem tree, has been used for millennia as a traditional remedy for a multitude of human ailments. Also recognized around the world as a broad-spectrum pesticide and fertilizer, neem has applications in agriculture and beyond. Currently, the extensive antimicrobial activities of A. indica are being explored through research in the fields of dentistry, food safety, bacteriology, mycology, virology, and parasitology. Herein, some of the most recent studies that demonstrate the potential of neem as a previously untapped source of novel therapeutics are summarized as they relate to the aforementioned research topics. Additionally, the capacity of neem extracts and compounds to act against drug-resistant and biofilm-forming organisms, both of which represent large groups of pathogens for which there are limited treatment options, are highlighted. Updated information on the phytochemistry and safety of neem-derived products are discussed as well. Although there is a growing body of exciting evidence that supports the use of A. indica as an antimicrobial, additional studies are clearly needed to determine the specific mechanisms of action, clinical efficacy, and in vivo safety of neem as a treatment for human pathogens of interest. Moreover, the various ongoing studies and the diverse properties of neem discussed herein may serve as a guide for the discovery of new antimicrobials that may exist in other herbal panaceas across the globe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Plant Products as Antimicrobial Agents
Cowan, M. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.564 · Cited by 9,043 · cited 1×
“…to extract different active components from plant products, most of the compounds that are thought to be responsible for the biological activities of neem can be found in the extracts that are typically used in laboratories (e.g., water, ethanol, methanol, chloroform, and ether) (Cowan, 1999).”
BackgroundNatural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Alzohairy, M. A. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/7382506 · Cited by 765
Nagata, J. M., Jew, A. R., Kimeu, J. M., Salmen, C. R., Bukusi, E. A., & Cohen, C. R. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.03.051 · Cited by 81 · cited 1×
“indica, that are traditionally used for HIV-associated infections (Nagata et al., 2011; Anywar et al., 2020), have been explored for their abilities to protect the CD4 T cell population that is vulnerable during HIV infection, to reduce persistent immune activation during ART, and to decrease the toxicity of ART drugs.”
BackgroundOyekanmi, A. A., Kumar, U. S. U., H. P. S., A. K., Olaiya, N. G., Amirul, A. A., Rahman, A. A., Nuryawan, A., Abdullah, C. K., & Rizal, S. (2021) · Polymers · doi:10.3390/polym13101664 · Cited by 45
Metadata
- Authors
- Wylie, M. R., & Merrell, D. S.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2022-05-30
- Volume
- 13
- Pages
- 891535-891535
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W4281669947
- Cited by
- 241
- References
- 7
- FWCI
- 20.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.